The Benefits

Deliver a Surgically-Proven Treatment for Mitral Valve Regurgitation with a routine percutaneous procedure

  • Lower the barrier to therapy for a large underserved patient population
  • Minimially invasive method to replicate mitral annuloplasty
  • Facilitate the early delivery of a clinically and economically superior treatment for MR
  • Leverage explosion of interest in endovascular valve procedures